Navigation Links
Best Drug for SARS

German investigators believe they have found a potential new drug that might be more effective in the treatment of severe acute respiratory syndrome (SARS) than drugs now being used against the deadly disease. In a research letter published in this week’s issue of The Lancet, the scientists outline results of a study comparing the standard drug used in SARS patients, ribavirin, with four additional antiviral drugs: 6-azauridine, pyrazofurin, mycophenolic acid, and glycyrrhizin. All were tested against two isolates of the SARS virus taken from SARS patients //being treated at Frankfurt University.

The study showed glycyrrhizin, which is used to treat some HIV and hepatitis C infections, was most effective in inhibiting replication of the SARS virus. Ribavirin and mycophenolic acid, by contrast, did not affect replication of the virus, and 6-azauridine and pyrazofurin inhibited replication, but less effectively than glycyrrhizin. Researchers aren’t sure how the drug does the job, but suspect it may be related to its effect on the increased synthesis of nitric oxide, which is known to inhibit replication of several viruses.

Investigators say glycyrrhizin should be studied further for a potential role in the treatment of SARS patients. They write, "Of all the compounds, glycyrrhizin was the most active in inhibiting replication of the SARS-associated virus.
'"/>




Page: 1

Related medicine news :

1. Extensive Campaigning To Warn Against Children’s Growing Affinity To Fast Food In Britai
2. Children’s Stress Levels Directly Related To Maternal Job Satisfaction
3. POCKET To Protect Children’s Privac
4. Children’s obesity linked to video game
5. Children’s Health Improves By Swimmin
6. Teething Problems – Fight Sugar For Children’s Dental Healh
7. Older Teenagers Too To be Treated In Children’s Hospital
8. Parents Unaware of their Children’s Knowledge about Household Firearm
9. Research Documents Children’s Exposure to Pesticide
10. Children’s Center to Lead Largest-Ever Study on Kidney Disease in Childre
11. Parental Time Influences Children’s Nutritio
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... ... August 18, 2017 , ... ... LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions ... definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... this summer’s edition of “Vision & Hearing,” advocating for active, healthy lifestyles and ... on resources available for individuals with hearing impairments and shares the latest innovations ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... handling handheld devices. Through an educational webinar, they will present the line of ... chance to learn how easy you can automate everyday pipetting tasks. , Ideal ...
(Date:8/18/2017)... ... August 18, 2017 , ... Hernandez Insurance Agencies, a northern ... the greater DC region, is inaugurating a “New Leash On Life” charity initiative ... training them to be companions for veterans in need. , The Semper K9 ...
(Date:8/18/2017)... ... 18, 2017 , ... Moore Insurance, a Houston area agency ... is launching a regional charity effort to provide publicity assistance and generate donations ... Tumor Foundation (PBTF) has raised nearly $30 million in donations that has been ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... ended June 30, 2017, and updated its financial outlook ... For the fiscal third quarter, Hill-Rom reported earnings ... diluted share in the prior-year period. These results reflect ... diluted share primarily related to the non-cash write-down of ...
(Date:7/27/2017)... July 27, 2017  West Pharmaceutical Services, Inc. (NYSE: ... for the second-quarter 2017 and updated financial guidance for ... Second-Quarter 2017 Highlights Reported net sales ... the prior-year quarter. Net sales at constant currency (organic) ... EPS was $0.51, compared to $0.60 in the prior-year ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: